|
Volumn 96, Issue 2, 2004, Pages 92-94
|
Are intellectual property rights hampering cancer research?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
RNA;
TRASTUZUMAB;
BREAST CANCER;
CANCER RESEARCH;
CANCER TRANSPLANTATION;
DISEASE MODEL;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
GENE ACTIVITY;
GENE EXPRESSION;
GENE INSERTION;
GENE TECHNOLOGY;
GENE THERAPY;
GENETIC ENGINEERING;
HEALTH CARE SYSTEM;
HUMAN;
LEGAL ASPECT;
LICENCE;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL SCHOOL;
NOTE;
ONCOGENE;
PATENT;
PRIORITY JOURNAL;
RNA TRANSLATION;
TRANSGENIC MOUSE;
TUMOR XENOGRAFT;
|
EID: 1042303681
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/96.2.92 Document Type: Note |
Times cited : (1)
|
References (0)
|